The lowest and highest of the models that produced a value. This is the spread of the methods, not a price target.
Price target range & 52-week position
Bear₩5,447.05Fair value₩13,141.06Bull₩19,280.00
FairClose
52-week traded range
52W low ₩22,600.0052W high ₩28,350.00
The 52-week range is measured from the stored price history, not estimated.
Valuation summary
Trading above the consensus fair value
Humedix Co., Ltd. closed at ₩26,050.00, 98.2% above the consensus fair value of ₩13,141.06 drawn from 10 valuation models.
Financial DNA score 43/100 — Average. P/E of 27.0x against the 20x sector multiple the P/E model uses.
Quantitative summary only — not investment advice.
All valuation models
DCF Valuation
₩9,780.94
-62.5%
Σ[CF×(1+g)^n/(1.10)^n] + TV/(1.10)^10
g=8%, r=10%, tg=3%, n=10yr
Graham Number
₩17,066.04
-34.5%
√(22.5 × EPS × BVPS)
EPS=964, BVPS=13427.84 · outside Graham range (P/E 27, P/B 1.9) — asset-light, treat as a rough floor
Graham Formula
₩10,925.33
-58.1%
EPS × (8.5 + 2g) × 4.4 ÷ FD_Rate
g=0%, FD=3.3%
P/E Fair Value
₩19,280.00
-26.0%
EPS × 20x (sector P/E)
EPS=964, Sector P/E=20x
Peter Lynch (PEG)
₩8,647.08
-66.8%
EPS × Growth% (PEG = 1 is fair)
EPS=964, g=9%
EV/EBITDA
₩15,335.54
-41.1%
(EBITDA × 10x − Net Debt) ÷ Shares
EBITDA=15.99B
Dividend Discount (DDM)
₩5,447.05
-79.1%
D1 ÷ (r − g) where D1 = D0×(1+g)
D0=427.22, r=10%, g=2%
Book Value (P/B)
₩8,037.52
-69.1%
BVPS × (ROE−g)÷(r−g) [Justified P/B — RIM-based]
BVPS=13427.84, ROE=7.2%, g=3%, r=10%
Reverse DCF
₩26,050.00
+0.0%
Solve for g: Price = Σ[EPS×(1+g)^n/(1.10)^n] + TV
Implied: 11.2% | Historical: -9%
Margin of Safety
₩10,697.31
-58.9%
Avg(DCF, Graham, P/E) × 75% (25% safety buffer)
Avg fair value=14263.08, MoS=25%
Computed on September 12, 2026 from the most recent annual report on file and that day's closing price. Where a company has seen its earnings move sharply since its last annual report, this figure will lag the market.
Educational data only. Not a recommendation to buy, sell or hold any security.